Pulmonary Arterial Hypertension (PAH): Causes, Risk Factors, and Classification
Pulmonary arterial hypertension (PAH) is a progressive disorder defined by a mean pulmonary arterial pressure ≥20 mmHg at rest (per 2022 ESC/ERS guidelines), caused by obstructive remodeling of the small pulmonary arteries. This increases right ventricular afterload, leading to right heart failure and premature death if untreated.
Etiology & Risk Factors
While the exact trigger is often unknown, several factors are implicated:
- Genetics: Mutations in BMPR2 (bone morphogenetic protein receptor type 2) account for ~75% of heritable PAH and ~20% of idiopathic cases. Other genes (ACVRL1, ENG, SMAD9, KCNK3, CAV1) are also linked.
- Associated Conditions (Associated PAH – APAH):
- Connective tissue diseases (systemic sclerosis, lupus, mixed connective tissue disease)
- Congenital heart disease (especially unrepaired systemic-to-pulmonary shunts)
- Portal hypertension / cirrhosis (portopulmonary hypertension)
- HIV infection
- Chronic hemolytic anemias (sickle cell, thalassemia)
- Drug & Toxin Exposure:
- Anorexigens (fenfluramine, dexfenfluramine, benfluorex)
- Amphetamines, methamphetamine, cocaine
- Certain chemotherapeutics (dasatinib)
- Chronic Thromboembolic Disease: Chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 3) can mimic PAH but has distinct pathophysiology and treatment (pulmonary endarterectomy).
- Age & Sex: Idiopathic PAH peaks in the 4th–5th decades; females are affected 2–4× more often than males.
Classification
- Idiopathic PAH (IPAH): No identifiable cause after thorough workup (~40–50% of cases).
- Heritable PAH (HPAH): Family history or pathogenic mutation identified.
- Associated PAH (APAH): Linked to conditions above.
- Drug/Toxin-Induced PAH: Temporal relationship with exposure.
Diagnostic Clues
Echocardiography estimates pulmonary pressures; right heart catheterization confirms diagnosis. Early referral to a PH specialist center improves outcomes, as targeted therapies (endothelin receptor antagonists, PDE-5 inhibitors, prostacyclin pathway agonists, sGC stimulators) can delay progression and improve quality of life.
Hypertension - Related Articles
- Quick Ways to Lower Blood Pressure: Natural Strategies & Tips
- Metoprolol: Understanding Uses, Dosage & Side Effects
- Manage High Blood Pressure: Causes, Prevention & Lifestyle Changes
- A History of Blood Pressure Measurement: From Early Concepts to Modern Devices
- Understanding High Blood Pressure: Causes, Risks & Effects
- Blood Circulation: How Much Blood Does the Heart Pump Per Hour?
- Low Pulse Pressure (9 mmHg) in an 18-Year-Old: Causes and Evaluation
